Abstract
The standard treatment for muscle-invasive bladder cancer (MIBC), total cystectomy, is highly invasive. Decreased quality of life (QOL) due to urinary diversion is a serious problem in patients with MIBC. In this study, we examined the therapeutic efficacy of cryoablation for MIBC in a mouse model of orthotopic bladder cancer and investigated its usefulness as a new treatment modality. Murine bladder cancer models were established by administering the chemical carcinogen N-butyl-N-(4-hydroxybutyl) nitrosamine. We monitored physiological parameters, including body weight, water intake, urine output, and urination frequency. Cryoablation was then performed on the tumor-bearing mice, and postoperative tumor progression and histological changes were evaluated. Physiological responses were tracked for up to post operative days 28 (POD 28) and compared with those in a non-operative group. Additionally, levels of CD4+ and CD8+ T cells were measured to evaluate immune activation following cryoablation. After cryoablation in the bladder cancer mouse model, we observed the following: (i) localized frostbite-induced injury to the muscle layer, which was gradually replaced by adjacent tissue; (ii) preservation of spontaneous urination post-surgery; and (iii) no procedure-related mortality. Moreover, a significant increase in CD4+ and CD8+ T cells was detected at POD 28. The efficacy, safety, and immune activation potential of cryoablation were confirmed in an orthotopic murine model of bladder carcinoma. Cryoablation for MIBC shows promise as a novel therapeutic approach for radical and bladder-sparing treatment with the potential to reduce metastatic disease.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5. (2025).
Kitamura, H. et al. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan clinical oncology group study JCOG0209. Ann. Oncol. 25, 1192–1198. https://doi.org/10.1093/annonc/mdu126 (2014).
Collaboration, A. B. C. A. M. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur. Urol. 48, 202–205. https://doi.org/10.1016/j.eururo.2005.04.006 (2005).
Chu, K. F. & Dupuy, D. E. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer. 14, 199–208. https://doi.org/10.1038/nrc3672 (2014).
Bahn, D. et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur. Urol. 62, 55–63. https://doi.org/10.1016/j.eururo.2012.03.006 (2012).
Liu, S. et al. The safety and efficacy of bladder cryoablation in a beagle model by using a novel balloon cryoprobe. Cryobiology 72, 157–160. https://doi.org/10.1016/j.cryobiol.2016.02.007 (2016).
Sutherland, D. E. et al. Bladder cryoablation in a Porcine model: evaluation of three surgical approaches and cryolesion predictability. J. Endourol. 23, 515–518. https://doi.org/10.1089/end.2008.0200 (2009).
Hruby, G. W. et al. Transurethral bladder cryoablation in the Porcine model. Urology 70, 391–395. https://doi.org/10.1016/j.urology.2007.03.028 (2007).
Abdo, J., Cornell, D. L., Mittal, S. K. & Agrawal, D. K. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers. Front. Oncol. 8, 85. https://doi.org/10.3389/fonc.2018.00085 (2018).
Vasconcelos-Nóbrega, C., Colaço, A., Lopes, C. & Oliveira, P. A. Review: BBN as an urothelial carcinogen. Vivo 26, 727–739 (2012).
Sugino, Y. et al. Voided stain on paper method for analysis of mouse urination. Neurourol. Urodyn. 27, 548–552. https://doi.org/10.1002/nau.20552 (2008).
Engelhardt, E. M. et al. A collagen-poly(lactic acid-co-ɛ-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials 32, 3969–3976. https://doi.org/10.1016/j.biomaterials.2011.02.012 (2011).
Jin, K. et al. CD103. Br. J. Cancer. 126, 1581–1588. https://doi.org/10.1038/s41416-022-01725-6 (2022).
Xu, G., Li, Y., Lu, G. & Xie, D. Tissue-resident memory T cells in urinary tract diseases. Front. Immunol. 16, 1535930. https://doi.org/10.3389/fimmu.2025.1535930 (2025).
Acknowledgements
We are grateful to Dr. Honjo for his advice regarding the VSOP method. We also thank Editage (https://www.editage.jp) for English editing.
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
S.I. made contributions to the conception, design, acquisition of data, and analysis. S.I. made contributions to the conception, design, analysis, wrote the main manuscript text, and approved the final version to be submitted. T.U. polished the manuscript. T.S., A.F., Y.I. and H.T. provided supervision. O.U. provided supervision and project administration. All authors have reviewed and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Inui, S., Ito, S., Ueda, T. et al. Efficacy and safety of cryoablation procedures using mouse models of bladder cancer. Sci Rep (2026). https://doi.org/10.1038/s41598-026-35571-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-35571-w
